TB-500 is a synthetic peptide derived from the active region of Thymosin Beta-4. In research settings, it is investigated for its interactions with actin polymerization, angiogenic signaling, and inflammatory regulation pathways, making it a subject of interest in studies on cytoskeletal dynamics and tissue response models.